Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-LGALS3/Galectin-3 Antibody (R1A61)

Catalog #:   RHD27103 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: FCM, IF, IHC, WB
Accession: P17931
Overview

Catalog No.

RHD27103

Species reactivity

Human, Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

Carbohydrate binding protein 35, CBP35, GAL3, Galactose-specific lectin 3, GALBP, Galectin3, GALIG, GBP, IgE binding protein, L31, LGALS2, LGALS3, Galectin 3

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P17931

Applications

FCM, IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4 ℃ short term (1-2 weeks). Store at -20 ℃ 12 months. Store at -80 ℃ long term.

Clone ID

R1A61

Data Image
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    Western blot analysis of Galectin 3 expression in A431 cell lysate.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
References

Discovery and affinity maturation of antibody fragments from an unfavorably enriched phage display selection by deep sequencing and machine learning., PMID:40473542

Galectin-3 modulates cellular infectivity and inflammatory response mediated by spike protein of SARS-CoV2., PMID:40253029

Immunohistochemical Expression of HBME-1 in a Spectrum of Thyroid Neoplasms., PMID:39881771

Bcl-2 and galectin-3 expression is associated with recurrence of ameloblastoma., PMID:39802810

Secreted LGALS3BP facilitates distant metastasis of breast cancer., PMID:39789641

Galectin-3 in metabolic disorders: mechanisms and therapeutic potential., PMID:39690058

Nanoparticle biosensors for cardiovascular disease detection., PMID:39681229

Fibrosis mechanisms in systemic sclerosis and new potential therapies., PMID:39656890

Evaluation of galectin-3 and titin in cats with a sarcomeric gene mutation associated with echocardiography., PMID:39619937

Immunohistochemical Study Protocol in Thyroid Pathology., PMID:39579319

The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial., PMID:39547392

Basophils induce protumorigenic cytokines from A549 lung adenocarcinoma via mechanisms requiring IgE, galectin-3, and IL-3 priming., PMID:39432748

Gal-3 blocks the binding between PD-1 and pembrolizumab., PMID:39357979

Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients., PMID:39337398

The GPI sidechain of Toxoplasma gondii inhibits parasite pathogenesis., PMID:39302131

FOSL1-mediated LINC01566 negatively regulates CD4+ T-cell activation in myasthenia gravis., PMID:39113081

Galectin-3 contributes to pathogenesis of IgA nephropathy., PMID:39084257

PRRSV utilizes MALT1-regulated autophagy flux to switch virus spread and reserve., PMID:39081059

Discovery of crucial cytokines associated with deep vein thrombus formation by protein array analysis., PMID:39026176

Integrated magneto-plasmonic nanostructures-based immunoassay for galectin-3 detection., PMID:39007190

Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2., PMID:38825040

Neutrophils impaired by anti-galectin-3 antibodies elicit inflammation of endothelial cells to aggregate the development of lupus cutaneous vasculitis., PMID:38757282

TLR2-ERK signaling pathway regulates expression of galectin-3 in a murine model of OVA-induced allergic airway inflammation., PMID:38754639

Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3'-diaminobenzidine-stained esophageal biopsies., PMID:38679488

BAP31 Promotes Angiogenesis via Galectin-3 Upregulation in Neuroblastoma., PMID:38474195

Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma., PMID:38438589

Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids., PMID:38332916

Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2., PMID:38289348

Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3., PMID:38259448

Galectin-3-binding protein inhibits extracellular heparan 6-O-endosulfatse Sulf-2., PMID:38187586

Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis., PMID:38162144

Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancer., PMID:38020309

Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma., PMID:37988837

Enzymatically-derived oligo-carrageenans interact with α-Gal antibodies and Galectin-3., PMID:37985065

Novel immune checkpoint targets: A promising therapy for cancer treatments., PMID:37979454

Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma., PMID:37951919

Galectin-3 does not interact with RNA directly., PMID:37815932

The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif., PMID:37788323

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints., PMID:37749326

Identifying Similar Allergens and Potentially Cross-Reacting Areas Using Structural Database of Allergenic Proteins (SDAP) Tools and D-Graph., PMID:37737991

Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1., PMID:37701441

Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis., PMID:37652913

LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma., PMID:37649401

IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies., PMID:37598939

Galectin-3 Plays an Important Role in BMP7-Induced Cementoblastic Differentiation of Human Periodontal Ligament Cells by Interacting with Extracellular Components., PMID:37396953

Inhibition of LPS-Induced Inflammatory Response of Oral Mesenchymal Stem Cells in the Presence of Galectin-3., PMID:37371614

Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy., PMID:37371482

Antibodies as Models and Tools to Decipher Candida albicans Pathogenic Development: Review about a Unique Monoclonal Antibody Reacting with Immunomodulatory Adhesins., PMID:37367572

TNF-α promotes CXCL-1/8 production in keratinocytes by downregulating galectin-3 through NF-κB and hsa-miR-27a-3p pathway to contribute psoriasis development., PMID:37358143

Galectin-3 Mediates NETosis and Acts as an Autoantigen in Systemic Lupus Erythematosus-Associated Diffuse Alveolar Haemorrhage., PMID:37298447

Datasheet
$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-LGALS3/Galectin-3 Antibody (R1A61) [RHD27103]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only